Shop Combivent Respimat Online | Buy Ipratropium Bromide & Albuterol Sulfate Inhaler
Combivent Respimat: Comprehensive Information
Combivent Respimat is a combination inhaler containing ipratropium bbromide and albuterol sulfate. It is a bronchodilator medication used to manage bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is available as a metered-dose inhaler (Respimat).
Composition
- Active Ingredients: Ipratropium bromide (an anticholinergic) and albuterol sulfate (a short-acting beta2-adrenergic agonist).
- Form of Release: Metered-dose inhaler (Respimat device) delivering a fine mist spray. Each inhalation delivers a specific dose of both active ingredients.
Indications
Combivent Respimat is indicated for the long-term, regular treatment of bronchospasm in patients with COPD who need more than one bronchodilator for optimal symptom control. It is not indicated for the initial treatment of acute episodes of bronchospasm where rapid-relief is required.
Mechanism of Action
Combivent Respimat works by relaxing the muscles in the airways, making it easier to breathe. Ipratropium bromide inhibits the action of acetylcholine on muscarinic receptors in the bronchial smooth muscle, leading to bronchodilation. Albuterol sulfate acts on beta2-adrenergic receptors in the lungs, causing relaxation of bronchial smooth muscle and preventing the release of mediators from mast cells, thus providing bronchodilation.
Safety Profile
- Benefits: Provides dual bronchodilation for improved breathing in COPD patients. The Respimat device ensures efficient delivery of the medication.
- Potential Side Effects: Common side effects may include cough, headache, nasopharyngitis (runny nose and sore throat), bronchitis, dizziness, and gastrointestinal upset. More serious side effects can include paradoxical bronchospasm, allergic reactions, changes in heart rate or blood pressure, and hypokalemia.
- Contraindications: Known hypersensitivity to ipratropium bromide, albuterol sulfate, or any component of the formulation. It is also contraindicated in patients with a history of hypersensitivity to atropine and its derivatives.
- Warnings: Use with caution in patients with cardiovascular disorders, hyperthyroidism, diabetes, or seizure disorders. Do not exceed the recommended doSe. If symptoms worsen or do not improve, seek medical attention.
Dosage Table
| Disease | Recommended Dosage | Treatment Duration |
|---|---|---|
| COPD (Chronic Bronchitis/Emphysema) | One inhalation, four times a day. | Long-term, regular treatment. |
Frequently Asked Questions
- Q: How should I use Combivent Respimat?
A: Inhale one puff four times daily. Prime the device before first use or if it has not been used for more than 3 days. Breathe in slowly and deeply through your mouth while pressing the dose-release button, then hold your breath for 10 seconds. Exhale slowly. Clean the mouthpiece weekly. - Q: Can Combivent Respimat be used for asthma?
A: Combivent Respimat is approved for COPD. While it contains albuterol, which is used for asthma, it is not typically the first-line treatment for asthma and should only be used as directed by a healthcare professional for asthma. - Q: What should I do if I miss a dose?
A: If you miss a dose, take it as soon as you remember. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one. - Q: How long does it take for Combivent Respimat to work?
A: The onset of action for ipratropium bromide is typically within 15-30 minutes, with peak effect at 1-2 hours. Albuterol sulfate acts rapidly, usually within 5 minutes. The cojbined effect provides sustained bronchodilation.
